Clinical trial · Observational
Faecal Incontinence in Prostate Cancer Survivors Treated Whith Radiotherapy
Faecal Incontinence in Prostate Cancer Survivors Treated With Moderately Hypofractionated Radiotherapy
NCT04262609CI-TRIAL-00105997active not recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The objective of the study is to determine the incidence of faecal incontinence in prostate cancer survivors treated with moderately hypofractionated radiation therapy and correlate the dose received by the anal sphincter with the degree of faecal incontinence.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Faecal Incontinence | — | UNRESOLVED | — |
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| hypofractionated radiotherapy | Radiation | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (5)
- measure
- faecal incontinence after prostate radiation therapy
- timeFrame
- before radiotherapy (basal)
- description
- grade of faecal incontinence in prostate cancer patients
- measure
- faecal incontinence after prostate radiation therapy
- timeFrame
- change 2 years after completion of radiotherapy
- description
- grade of faecal incontinence in prostate cancer survivors
- measure
- faecal incontinence after prostate radiation therapy
- timeFrame
- change 3 years after completion of radiotherapy
- description
- grade of faecal incontinence in prostate cancer survivors
- measure
- faecal incontinence after prostate radiation therapy
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Prostate cancer survivors treated in our department by hypofractionated radiotherapy Exclusion Criteria: * Relapse of prostate cancer * Other active cancer * Mental disorder
References
Publications (1)
- DERIVEDLozano J, Feltes N, Colomer M, Lizondo M, Carmona M, Romero C, Ribas Y, Paredes S, Galdeano M, Sole JM. Fecal incontinence after moderately hypofractionated volumetric modulated arc therapy for prostate cancer: incidence and impact on quality of life. Clin Transl Oncol. 2025 Oct;27(10):4003-4010. doi: 10.1007/s12094-025-03926-w. Epub 2025 Apr 22. PMID 40261490